# PhysIQ

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/physiq

- Industry: Software
- Headquarters: Naperville, US
- Website: www.physiq.com
- Total disclosed funding: $13M
- Latest round: Series B (Jul 25, 2017)
- Investors on record: 4

## About

PhysIQ, Inc. specializes in advanced health monitoring solutions, leveraging sophisticated algorithms and data analytics to enable real-time monitoring of patients' physiological data for improved healthcare outcomes.Founded in 2013 in Naperville, US, PhysIQ, Inc. operates within the healthcare technology space, focusing on continuous health monitoring. The company was co-founded by Gary Conkright and Matt Pipke, with Gary Conkright currently serving as CEO. PhysIQ has raised a total of USD 3.30 mn across 6 funding deals, with its latest funding round being a USD 3.30 mn venture funding from Wasson Enterprise.PhysIQ provides advanced health monitoring solutions through its flagship product, the physIQ platform. This platform utilizes sophisticated algorithms and data analytics to continuously monitor patients' physiological data, assisting healthcare providers in detecting health changes in real time. The platform collects data via wearable devices, informing clinical decision-making and enhancing patient outcomes. PhysIQ's client base includes hospitals, healthcare systems, and clinical research organizations, predominantly in the United States and select international markets.PhysIQ operates on a subscription-based revenue model, offering various pricing plans tailored to client needs. Healthcare providers engage with PhysIQ through structured subscription agreements, granting them access to real-time monitoring, analytics, and reporting features. This model facilitates consistent revenue generation while providing ongoing support to clients, enhancing patient care through seamless integration into existing healthcare workflows.PhysIQ plans to expand its product offerings and geographical reach in the coming years. The company is designing new products aimed at enhancing patient monitoring capabilities, although specific release dates have not been publicly disclosed. Targeted geographic expansion includes markets outside the US, with plans to establish a presence in additional international regions. The recent funding of USD 3.30 mn from Wasson Enterprise will support these initiatives, allowing PhysIQ to further enhance its platform and explore new market opportunities.

## Funding rounds

- Series B, Jul 25, 2017, $8M — LionBird, 4490 Ventures, GF Securities, Quark Venture
- Series A, Jul 24, 2014, $4.6M — LionBird

## Investors

- LionBird (https://capitalatlas.ai/funds/lionbird) — Series A, Series B
- 4490 Ventures (https://capitalatlas.ai/funds/4490-ventures) — Series B
- GF Securities — Series B
- Quark Venture (https://capitalatlas.ai/funds/quark-venture) — Series B